These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 20405211)

  • 21. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness.
    Ragunath K; Krasner N; Raman VS; Haqqani MT; Phillips CJ; Cheung I
    Scand J Gastroenterol; 2005 Jul; 40(7):750-8. PubMed ID: 16118910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic therapy of esophageal premalignancy and early malignancy.
    Nealis TB; Washington K; Keswani RN
    J Natl Compr Canc Netw; 2011 Aug; 9(8):890-9. PubMed ID: 21900219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiofrequency ablation for low-grade dysplasia in Barrett's esophagus.
    Nayna L; Emma W; Vani K
    Curr Opin Gastroenterol; 2016 Jul; 32(4):294-301. PubMed ID: 27070914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia.
    Small AJ; Araujo JL; Leggett CL; Mendelson AH; Agarwalla A; Abrams JA; Lightdale CJ; Wang TC; Iyer PG; Wang KK; Rustgi AK; Ginsberg GG; Forde KA; Gimotty PA; Lewis JD; Falk GW; Bewtra M
    Gastroenterology; 2015 Sep; 149(3):567-76.e3; quiz e13-4. PubMed ID: 25917785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal Ablation Techniques for Barrett's Esophagus and Early Esophageal Cancer.
    Rajaram R; Hofstetter WL
    Thorac Surg Clin; 2018 Nov; 28(4):473-480. PubMed ID: 30268293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
    Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
    Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radio frequency ablation of dysplastic Barrett's esophagus: Outcomes of a single-center registry.
    Mathiesen M; Holm J; Thorsteinsson M
    Scand J Surg; 2023 Jun; 112(2):86-90. PubMed ID: 36756673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of liquid nitrogen cryotherapy after failed radiofrequency ablation for Barrett's esophagus.
    Trindade AJ; Inamdar S; Kothari S; Berkowitz J; McKinley M; Kaul V
    Dig Endosc; 2017 Sep; 29(6):680-685. PubMed ID: 28303613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry.
    Haidry RJ; Dunn JM; Butt MA; Burnell MG; Gupta A; Green S; Miah H; Smart HL; Bhandari P; Smith LA; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Novelli M; Banks MR; Lovat LB
    Gastroenterology; 2013 Jul; 145(1):87-95. PubMed ID: 23542069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer.
    Thota PN; Arora Z; Dumot JA; Falk G; Benjamin T; Goldblum J; Jang S; Lopez R; Vargo JJ
    Dig Dis Sci; 2018 May; 63(5):1311-1319. PubMed ID: 29524114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of Radiofrequency Ablation versus Endoscopic Surveillance for Barrett's Esophagus with Low-Grade Dysplasia: A Systematic Review and Meta-Analysis.
    Klair JS; Zafar Y; Nagra N; Murali AR; Jayaraj M; Singh D; Rustagi T; Krishnamoorthi R
    Dig Dis; 2021; 39(6):561-568. PubMed ID: 33503615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic eradication therapy for mucosal neoplasia in Barrett's esophagus.
    Dunbar KB
    Curr Opin Gastroenterol; 2013 Jul; 29(4):446-53. PubMed ID: 23703368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry.
    Ganz RA; Overholt BF; Sharma VK; Fleischer DE; Shaheen NJ; Lightdale CJ; Freeman SR; Pruitt RE; Urayama SM; Gress F; Pavey DA; Branch MS; Savides TJ; Chang KJ; Muthusamy VR; Bohorfoush AG; Pace SC; DeMeester SR; Eysselein VE; Panjehpour M; Triadafilopoulos G;
    Gastrointest Endosc; 2008 Jul; 68(1):35-40. PubMed ID: 18355819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of radiofrequency ablation of Barrett's esophagus in the absence of reimbursement: a multicenter prospective Belgian registry.
    Vliebergh JH; Deprez PH; de Looze D; Ferrante M; Orlent H; Macken E; Christiaens P; Mana F; De Hertogh G; Willekens H; Bisschops R
    Endoscopy; 2019 Apr; 51(4):317-325. PubMed ID: 30360011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus.
    Titi M; Overhiser A; Ulusarac O; Falk GW; Chak A; Wang K; Sharma P
    Gastroenterology; 2012 Sep; 143(3):564-566.e1. PubMed ID: 22561053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Outcomes Following Recurrence of Intestinal Metaplasia After Successful Treatment of Barrett's Esophagus With Radiofrequency Ablation.
    Guthikonda A; Cotton CC; Madanick RD; Spacek MB; Moist SE; Ferrell K; Dellon ES; Shaheen NJ
    Am J Gastroenterol; 2017 Jan; 112(1):87-94. PubMed ID: 27725648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cost-utility analysis of ablative therapy for Barrett's esophagus.
    Inadomi JM; Somsouk M; Madanick RD; Thomas JP; Shaheen NJ
    Gastroenterology; 2009 Jun; 136(7):2101-2114.e1-6. PubMed ID: 19272389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radio frequency ablation of Barrett's esophagus--can the risk of esophageal adenocarcinoma be reduced?].
    Salminen P; Räsänen J; Ristimäki A; Saarnio J; Heikkinen M; Laine S; Koivisto T; Färkkilä M
    Duodecim; 2014; 130(6):557-64. PubMed ID: 24724454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.
    Sawas T; Alsawas M; Bazerbachi F; Iyer PG; Wang KK; Murad MH; Katzka DA
    Gastrointest Endosc; 2019 May; 89(5):913-925.e6. PubMed ID: 30529044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.